Development and longevity of antibodies against SARS-CoV-2 in kidney transplant recipients after symptomatic COVID-19.
Transpl Infect Dis
; 23(4): e13646, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-34028939
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Kidney Transplantation
/
COVID-19
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Transpl Infect Dis
Journal subject:
TRANSPLANTE
Year:
2021
Type:
Article
Affiliation country:
India